Orchestra BioMed (OBIO) Misses Q1 EPS by 33c

Orchestra BioMed (NASDAQ: OBIO) reported Q1 EPS of ($0.33). Revenue for the quarter came in at $110 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Wealthfront launches custodial account with tax-gain harvesting
• Johnson Controls (JCI) 4K contracts of August 120 puts trade, share price down 4%